Ductal carcinoma in situ (DCIS) is a pre-invasive breast cancer that may be overtreated due to lack of reliable clinical and pathological prognostic features. Kinetics parameters on dynamic contrast-enhanced MRI have shown promise as breast cancer risk biomarkers. We compared imaging parameters of lesions and normal breast tissue between patients with DCIS recurrence and matched controls and found that patients with larger lesions with higher signal enhancement ratio (SER) and higher background parenchymal enhancement (BPE) on preoperative MRI were more likely to recur. These MRI biomarkers show promise for decreasing DCIS overtreatment and warrant further study in larger cohorts.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords